Virtually all wounds contain bacteria but the type and number of bacteria, their phenotype, as well as the way they are organized determine to what extent they may be harmful to a (skin) lesion and its healing process.
This Thursday and Friday, DEBx Medical will be a virtual participant in the online edition of the Innovation for Health conference 2021. We will be
DEBRICHEM is a disruptive new treatment option to address the infection in hard to heal wounds. The topical gel offers a very effective alternative to
Last Friday, a new article about DEBx Medical and our product DEBRICHEM was published online on Bioworld Medtech. The article states, among other things, that
Rotterdam, The Netherlands, March 19, 2021 – In early February, we finally obtained our ISO 13485:2016 certificate and our CE-certificate for DEBRICHEM. DEBRICHEM is a topical desiccantion gel for chemical
The presence of a biofilm in a wound is known to be detrimental to wound healing as is the case with the presence of necrosis
